. 2016 Apr 7;10(4):e0004607. doi: 10.1371/journal.pntd.0004607

Table 2. Identified differential metabolites between DF and DHF patients in the febrile phase of infection.

HMDB	Accurate mass	Metabolite	Chemical formula	p value	Fold change (DHF/DF)	Pathway
HMDB00684	208.0817	L-Kynurenine	C₁₀H₁₂N₂O₃	0.001	1.7	Tryptophan metabolism
HMDB29006	351.1524	phenylalanyl-tryptophan	C₂₀H₂₁N₃O₃	0.007	0.57	Dipeptide
HMDB02117	281.2677	oleamide	C₁₈H₃₅NO	0.002	0.23	Fatty acid amide
HMDB13243	278.1582	Leucyl-phenylalanine	C₁₅H₂₂N₂O₃	0.02	0.39	Dipeptide
HMDB00583	337.3271	Docosenamide	C₂₂H₄₅NO	0.02	3.49	Fatty acid amide
HMDB00071	252.0814	Deoxyinosine	C₁₀H₁₂N₄O₄	0.005	1.7	Purine metabolism
HMDB28922	202.1268	Leucyl-Alanine	C₉H₁₈N₂O₃	0.01	0.43	Dipeptide
HMDB00259	176.0928	Serotonin	C₁₀H₁₂N₂O	0.004	0.64	Tryptophan metabolism
HMDB12273	255.2517	Palmitic amide	C₁₆H₃₃NO	0.002	0.16	Fatty acid amide
HMDB12378	791.558	PS (18:0/18:0)	C₄₂H₈₂NO₁₀P	0.0001	1.62	Glycerophospholipid
HMDB13302	312.1486	Phenylalanylphenylalanine	C₁₈H₂₀N₂O₃	0.02	0.61	Dipeptide
HMDB00054	584.2643	Bilirubin	C₃₃H₃₆N₄O₆	0.02	1.58	Porphyrin and chlorophyll metabolism
HMDB61112	240.1017	CMPF	C₁₂H₁₆O₅	0.03	1.59	Fatty acid
HMDB11523	529.3201	LPE(22:4/0:0)	C₂₇H₄₈NO₇P	0.02	0.66	Glycerophospholipid
HMDB09044	791.5411	PE(18:1/22:5)	C45H78NO8P	0.02	0.57	Glycerophospholipid
HMDB09397	789.5349	PE (20:4/20:3)	C₄₅H₇₆NO₈P	0.009	1.54	Glycerophospholipid
HMDB09414	749.5394	PE(20:4/P-18:1)	C₄₃H₇₆NO₇P	0.007	0.69	Glycerophospholipid
HMDB11511	509.3548	LPE(20:0/0:0)	C₂₅H₅₂NO₇P	0.01	0.72	Glycerophospholipid
HMDB10164	819.6028	PS(18:0/20:0)	C₄₄H₈₆NO₁₀P	0.02	0.71	Glycerophospholipid
HMDB13010	187.1177	N-Heptanoylglycine	C₉H₁₇NO₃	0.009	2.07	Acylglycine